Education
About Us
Working with TipRanks
Follow Us
CHARLES BRYNELSEN Insider Profile
4 Followers
CHARLES BRYNELSEN, SVP at Abbott Laboratories, holds 50.00K shares in Envoy Medical (Ticker: COCH), holds 43.55K shares in Abbott Laboratories (Ticker: ABT). Most recently, CHARLES BRYNELSEN Bought ― shares of Envoy Medical on May 27, 2025 for an estimated value of 82.08K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-1.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that CHARLES BRYNELSEN holds in companies
Most Profitable Insider Trade
The most profitable trade made by CHARLES BRYNELSEN
CHARLES BRYNELSEN's Trading History
Abbott Laboratories
Mar 02, 2021
SVP
Uninformative Sell
979.21K
$5.39M
Envoy Medical
May 27, 2025
Director
Informative Buy
82.08K
$80.50K
List of latest transactions for each holding click on a transaction to see CHARLES BRYNELSEN's performance on stock
You May Also Like
CHARLES BRYNELSEN insider profile FAQ
What is the percentage of profitable transactions made by CHARLES BRYNELSEN?
The percentage of profitable transactions made by CHARLES BRYNELSEN is 50%.
What is the average return per transaction made by CHARLES BRYNELSEN?
The average return per transaction made by CHARLES BRYNELSEN is -1.40%.
What stocks does CHARLES BRYNELSEN hold?
CHARLES BRYNELSEN holds: ABT, COCH stocks.
What was CHARLES BRYNELSEN’s latest transaction?
CHARLES BRYNELSEN latest transaction was an Informative Buy of $82.08K.
What was CHARLES BRYNELSEN's most profitable transaction?
CHARLES BRYNELSEN’s most profitable transaction was an Informative Buy of COCH stock on May 27, 2025. The return on the trade was 3.20%.
What is CHARLES BRYNELSEN's role in Abbott Laboratories?
CHARLES BRYNELSEN's role in Abbott Laboratories is SVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.